Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 17, 2024 - Issue
Submit an article Journal homepage
147
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

LncRNA HCP5 is Highly Expressed in Gestational Diabetes Mellitus to Suppress Insulin Secretion

Hu Zhao1 Department of Gynecology and Obstetrics, Sichuan University West China Second University Hospital, Chengdu, Sichuan, People’s Republic of ChinaView further author information
,
Jun Zhan1 Department of Gynecology and Obstetrics, Sichuan University West China Second University Hospital, Chengdu, Sichuan, People’s Republic of ChinaView further author information
,
Qiong Wang2 Department of Gynecology and Obstetrics, Chengdu Women and Children’s Central Hospital, Chengdu, Sichuan, People’s Republic of ChinaView further author information
,
Shuqi Yang1 Department of Gynecology and Obstetrics, Sichuan University West China Second University Hospital, Chengdu, Sichuan, People’s Republic of ChinaView further author information
&
Xue Xiao1 Department of Gynecology and Obstetrics, Sichuan University West China Second University Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 157-163 | Received 09 Mar 2023, Accepted 07 Nov 2023, Published online: 08 Jan 2024

References

  • McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi:10.1038/s41572-019-0098-8
  • Szmuilowicz ED, Josefson JL, Metzger BE. Gestational diabetes mellitus. Endocrinol Metab Clin North Am. 2019;48(3):479–493. doi:10.1016/j.ecl.2019.05.001
  • Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40(9):899–909. doi:10.1007/s40618-016-0607-5
  • Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743–754. doi:10.1016/j.tem.2018.09.004
  • McKenzie-Sampson S, Paradis G, Healy-Profitós J, St-Pierre F, Auger N. Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study. Acta Diabetol. 2018;55(4):315–322. doi:10.1007/s00592-017-1099-2
  • Zhu H, Chen B, Cheng Y, et al. Insulin therapy for gestational diabetes mellitus does not fully protect offspring from diet-induced metabolic disorders. Diabetes. 2019;68(4):696–708. doi:10.2337/db18-1151
  • Guo M, Lu J, Yu X, Hu X, Hou W, Pang S. The protective role of serum uric acid against premature membrane rupture in gestational diabetes: a cross-sectional study. BMC Endocr Disord. 2021;21(1):95. doi:10.1186/s12902-021-00736-3
  • Muller PS, Sundaram SM, Nirmala M, Nagarajan E. Application of computational technique in design of classifier for early detection of gestational diabetes mellitus. Appl Mathemat Sci. 2015;9:3327–3336. doi:10.12988/ams.2015.54319
  • Alyas S, Roohi N, Ashraf S, Ilyas S, Ilyas A. Early pregnancy biochemical markers of placentation for screening of gestational diabetes mellitus (GDM). Diabetes Metab Syndr. 2019;13(4):2353–2356. doi:10.1016/j.dsx.2019.06.006
  • Nguyen-Ngo C, Jayabalan N, Salomon C, Lappas M. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol. 2019;63(3):R51–R72. doi:10.1530/JME-18-0274
  • Dias S, Pheiffer C, Abrahams Y, Rheeder P, Adam S. Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci. 2018;19(10):2926. doi:10.3390/ijms19102926
  • Lu J, Wu J, Zhao Z, Wang J, Chen Z. Circulating LncRNA serve as fingerprint for gestational diabetes mellitus associated with risk of macrosomia. Cell Physiol Biochem. 2018;48(3):1012–1018. doi:10.1159/000491969
  • Wang X, Liu Y, Rong J, Wang K. LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis. BMC Endocr Disord. 2021;21(1):134. doi:10.1186/s12902-021-00781-y
  • Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a. Eur Rev Med Pharmacol Sci. 2018;22(15):4812–4819. doi:10.26355/eurrev_201808_15616
  • Zhao C, Li Y, Hu X, et al. LncRNA HCP5 promotes cell invasion and migration by sponging miR-29b-3p in human bladder cancer. Onco Targets Ther. 2020;13:11827–11838. doi:10.2147/OTT.S249770
  • Wang X, Liu Y, Rong J, et al. LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis. BMC Endocr Disord. 2021;21(1):1–14.
  • Wong VW, Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy? Aust N Z J Obstet Gynaecol. 2011;51(5):432–436. doi:10.1111/j.1479-828X.2011.01329.x

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.